Outlook Therapeutics competitors

View the competitive landscape for Outlook Therapeutics, featuring companies like Novartis, Kalaris Therapeutics, and Merck. Mapping a different industry? Browse our competitor database or generate a competitor list for any company.

Outlook Therapeutics

Late-stage biopharmaceutical company developing ophthalmic bevacizumab

List of Outlook Therapeutics competitors

Novartis

Pharmaceutical firm marketing various treatments for neovascular age-related macular degeneration
novartis.com
Kalaris Therapeutics

Clinical-stage biopharmaceutical company developing retinal disease treatments
kalaristx.com
Merck

Biotechnology company advancing clinical programs for diabetic macular edema
merck.com
Roche

Global healthcare company providing innovative biologics for wet AMD treatment
roche.com
Regeneron

Biotechnology company manufacturing leading anti-VEGF therapies for retinal disorders
regeneron.com
EyePoint Pharmaceuticals

Company developing sustained-release therapeutics for serious retinal diseases
eyepoint.bio
Ocular Therapeutix

Biopharmaceutical company focused on hydrogel-based formulations for eye conditions
ocutx.com
Kodiak Sciences

Clinical-stage company developing antibody biopolymer conjugates for retinal diseases
kodiak.com
REGENXBIO

Clinical-stage biotechnology company developing gene therapies for retinal conditions
regenxbio.com
Adverum Biotechnologies

Clinical-stage gene therapy company targeting ocular and rare diseases
adverum.com
Opthea

Biopharmaceutical company developing VEGF-C/D trap therapies for wet AMD
opthea.com

Track Outlook Therapeutics & Its Competitors

Follow their latest moves with a real-time news feed and summaries delivered straight to your inbox.

Browse competitors related to Outlook Therapeutics and other trending companies.